KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $141.98 $159.34 Friday, 26th Apr 2024 ALNY stock ended at $143.31. This is 0.278% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.14% from a day low at $143.00 to a day high of $146.07.
90 days $141.98 $181.66
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Mar 07, 2016 $60.09 $60.09 $60.09 $60.09 1 049 300
Mar 04, 2016 $59.18 $59.18 $59.18 $59.18 1 010 100
Mar 03, 2016 $59.98 $59.98 $59.98 $59.98 1 060 500
Mar 02, 2016 $62.63 $62.63 $62.63 $62.63 1 333 700
Mar 01, 2016 $59.83 $59.83 $59.83 $59.83 1 846 200
Feb 29, 2016 $58.57 $58.57 $58.57 $58.57 1 762 600
Feb 26, 2016 $58.00 $58.00 $58.00 $58.00 847 100
Feb 25, 2016 $56.86 $56.86 $56.86 $56.86 882 700
Feb 24, 2016 $58.02 $58.02 $58.02 $58.02 1 061 500
Feb 23, 2016 $59.45 $59.45 $59.45 $59.45 650 800
Feb 22, 2016 $62.68 $62.68 $62.68 $62.68 833 200
Feb 19, 2016 $63.52 $63.52 $63.52 $63.52 1 342 800
Feb 18, 2016 $62.49 $62.49 $62.49 $62.49 1 010 100
Feb 17, 2016 $65.70 $65.70 $65.70 $65.70 1 141 600
Feb 16, 2016 $63.90 $63.90 $63.90 $63.90 1 495 700
Feb 12, 2016 $59.55 $59.55 $59.55 $59.55 1 917 900
Feb 11, 2016 $56.96 $56.96 $56.96 $56.96 1 401 700
Feb 10, 2016 $57.00 $57.00 $57.00 $57.00 1 383 800
Feb 09, 2016 $59.22 $59.22 $59.22 $59.22 1 629 600
Feb 08, 2016 $60.61 $60.61 $60.61 $60.61 1 128 900
Feb 05, 2016 $65.59 $65.59 $65.59 $65.59 1 316 900
Feb 04, 2016 $67.51 $67.51 $67.51 $67.51 1 454 800
Feb 03, 2016 $66.13 $66.13 $66.13 $66.13 1 428 100
Feb 02, 2016 $64.91 $64.91 $64.91 $64.91 1 129 900
Feb 01, 2016 $69.75 $69.75 $69.75 $69.75 1 343 700
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT